Brigham and Women's Hosp. ACTG CRS is a clinical research site located in Boston, Massachusetts, United States.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Brigham and Women's Hosp. ACTG CRS has participated in 13 clinical trials.
Therapeutic areas: HIV Infections, HIV Infection, Cytomegalovirus Infections.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Brigham and Women's Hosp. ACTG CRS has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Brigham and Women's Hosp. ACTG CRS has 13 clinical trials on record. Their work covers HIV Infections, HIV Infection, Cytomegalovirus Infections.
Yes — Brigham and Women's Hosp. ACTG CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.